# Apotex, Inc. – FDA Inspection, Jul 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/apotex-inc/8f560e23-4ace-4769-92c5-5cf425bcfb61
Source feed: FDA_Inspections

> FDA inspection 1100432 of Apotex, Inc., July 12, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1100432
- Company Name: Apotex, Inc.
- Inspection Date: 2019-07-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1249246 - 2024-09-27
- FDA Inspection 1230073 - 2024-02-23
- FDA Inspection 1114893 - 2019-11-08
- FDA Inspection 1035875 - 2017-12-08
- FDA Inspection 982370 - 2016-05-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/apotex-inc/3fb3d66a-fef9-4c47-82b5-da446ecf3593

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c